Effects of Nanogold on the Alleviation of Carbon Tetrachloride-Induced Hepatic Injury in Rats

Yi-Peng Chen ； Zong-Her Dai ； Pan-Chen Liu ； Jiunn-Jye Chuu ； Kuo-Yang Lee ； Shun-Lai Lee ； Yun-Ju Chen

《The Chinese Journal of Physiology》 55卷5期 (2012/10) Pp. 331-336

https://doi.org/10.4077/CJP.2012.BAA064

並列摘要

Gold particles have been used in complementary medicine for decades, and many beneficial effects have been reported. Our present study sought to evaluate the therapeutic effects of nanogold in carbon tetrachloride (CCl4)-injured liver of rats. Male SD rats were subjected to liver injury induction by CCl4, then the rats were fed with zero to high dose (0, 1, 5 or 10 ppm) of nanogold water every day for 4 weeks. Biochemical analyses on liver functions were then performed to evaluate the therapeutic effects of nanogold. Our results revealed that gold nanoparticles lowered serum aspartate aminotransaminase (AST) and alanine aminotransferase and exerted serum total protein-recovering effects, which might be partially associated with the elevation of anti-inflammatory cytokine IL-10 level. In addition, serum triglyceride level fell after continuous ingestion of nanogold. Finally, the experimental animals recovered body weight after 4 weeks of nanogold ingestion. This is the first report indicating inflammationalleviating effects of nanogold on hepatic injury.

並列關鍵字

alanine aminotransferase ； aspartate aminotransferase ； hepatic injury ； IL-10 ； nanogold

參考文獻

Abraham, G. E.(2008).Clinical applications of gold and silver nanocolloids.Original Internist.15,132-157.

Abraham, G. E.,Himmel, P. B.(1997).Management of rheumatoid arthritis: Rationale for the use of colloidal metallic gold.J. Nutr. Environ. Med..7,295-305.

Ackerman, G. A. M.,Wolken, K. W.(1981).Histochemical evidence for the differential surface labeling. Uptake, and intracellular transport of a colloidal gold-labeled insulin complex by normal human blood cells.J. Histochem. Cytochem..29,1137-1149.

Blocka, K. L.,Paulus, H. E.,Furst, D. E.(1986).Clinical pharmacokinetics of oral and injectable gold compounds.Clin. Pharmacokinet..11,133-143.

Campbell, J. M.,Reglinski, J.,Smith, W. E.,Porter, D.,Sturrock, R. D.(1992).Action of sodium aurothiomalate on erythrocyte membrane.Ann. Rheum. Dis..51,969-971.